-
Biotech company Tempest surged nearly 4,000%! The latest data confirms the positive results of liver cancer therapy
[Biotech company Tempest skyrocketed 3,972%! New data confirms positive results for liver cancer therapy] On Wednesday, Tempest Therapeutics, Inc., a clinical-stage oncology company. Shares surged 3,9 ... -
Forty times in one day! Us biotech company liver cancer therapy now positive results also announced "poison pill program"
On the 11th local time, the three major US stock indexes closed up for the fourth consecutive day. By the close, the Dow was up 0.19%, the S&P 500 was up 0.43%, and the Nasdaq was up 0.71%. The Fed mi ... -
Functional makeup stimulates market enthusiasm, perfect diary expands biotechnology research and development territory
Domestic beauty products may be entering the next stage of new demand for skincare and makeup, and "collaborative research and development" has become the key. At the recently held "bionic film" esse ... -
$1.2 billion sold to AstraZeneca Genxi Biotechnology, becoming the first Chinese biotech company to be acquired by a multinational pharmaceutical company
The biopharmaceutical industry is still in a capital winter period, and there is an increasing trend of mergers and acquisitions in the industry. On December 26, 2023, AstraZeneca announced that it h ...- dongjinwei
- 2023-12-26
- サポート
- に反対
- 返信
- コレクション
-
The financial reports of the biotechnology sector have been released one after another, with the largest market value of Abbott's declining profits | from Wall Street to Lujiazui
Abbott's financial report is poor. The annual revenue was 54.3 billion, a decrease of 6%, but operating costs increased by 13% and R&D expenses increased by 9% to reach 7 billion, but this is a good ...